Released: 30-Jan-2012 4:05 PM EST
BrainStorm Cell Therapeutics (OTCBB:BCLI) Has Potentially Developed A Treatment For ALS
 Investor Stem Cell

Last week a U.S. company announced initial Phase I/II clinical trial results for ALS (Amyotrophic Lateral Sclerosis).

Comment